| Outcome Measures: |
Primary: Flow Mediated Dilation, Change from baseline Flow mediated dilation at 7 days. Using a high-resolution UNEX EF38G ultrasound®, in a room at 22°C, with the patient lying supine, and the right arm extended, 7 days | Secondary: Fasting plasma glucose, Before and after intervention, using the BioSystems® Glucose Oxidase / Peroxidase kit; in an automated clinical chemistry analysis equipment brand XL-100Erba, 7 days|Total cholesterol, Before and after intervention, using the BioSystems® Glucose Oxidase / Peroxidase kit., 7 days|Triglycerides, Before and after intervention, using the BioSystems® Glycerol phosphate Oxidase / Peroxidase kit., 7 days|High-density lipoprotein cholesterol, Before and after intervention, using the BioSystems® Direct / Detergent HDL kit, 7 days|Low-density lipoprotein cholesterol, Before and after intervention using the BioSystems® Cholesterol Oxidase / Peroxidase kit, 7 days|Creatinine, Before and after intervention the BioSystems® kit Modified Jaffe's no deproteinization, 7 days|Blood pressure, Before and after intervention using an OMRON calibrated electronic digital sphygmomanometer model HEM 907 XL will be used. The patient will remain seated in a chair resting his back on the backrest, with a minimum rest of 5 minutes, The average of 3 measurements such as BP will be taken, 7 days
|
